Publikationen

Die vollständige Publikationsliste findet man hier.

Gardiner SL, Boogaard MW, Trompet S, de Mutsert R, Rosendaal FR, Gussekloo J, Jukema JW, Roos RA, Aziz NA. High prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles in large population-based cohorts. JAMA Neurol. 2019 Jan 01; 76:650-656. doi: 10.1001/jamaneurol.2019.0423
Gardiner SL, Trompet T, Sabayan B, Boogaard BW, Jukema W, Slagboom PE, Roos RA, Van der Grond J, Aziz NA. Repeat variations in polyglutamine disease-associated genes and cognitive function in old age. Neurobiol Aging. 2019 Jan 01; 84:236.e17-236.e28. doi: 10.1016/j.neurobiolaging.2019.08.002
Aziz NA, Van der Burg JM, Tabrizi SJ, Landwehrmeyer GB. Overlap between age of onset and progression determinants in Huntington disease. Neurology. 2018 Jan 01; 90:2099-2106. doi: 10.1212/WNL.0000000000005690
Gardiner SL, Harder AV, Campman YJ, Trompet S, Gussekloo J, Van Belzen MJ, Boogaard MW, Roos RA, Jansen IE, Pijnenburg YA, Scheltens Ph, Van der Flier WM, Aziz NA. Repeat length variations in polyglutamine disease-associated genes modify disease expression in Alzheimer disease. Neurobiol Aging. 2019 Jan 01; 73:230.e9-17. doi: 10.1016/j.neurobiolaging.2018.09.007
Keo A, Aziz NA, Dzyubachyk O, Van der Grond J, Roon-Mom WM, Lelieveldt BF, Reinders MJ, Mahfouz A. Co-expression patterns between ATN1 and ATXN2 coincide with brain regions affected in Huntington's disease. Frontiers in Molecular Neuroscience. 2017 Jan 01; 10:399. doi: 10.3389/fnmol.2017.00399
Gardiner SL, Van Belzen MJ, Boogaard MW; Van Roon-Mom WM, Rozing MP, Van Hemert AM, Smit JH, Beekman AT, Van Grootheest G, Schoevers RA, Oude Voshaar RC, Comijs HC, Penninx BW, Van der Mast RC, Roos RA, Aziz NA. Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression. Translational Psychiatry. 2017 Jan 01; 7:e1143. doi: 10.1038/tp.2017.116
Van der Burg JM, Gardiner SL, Ludolph AC, Landwehrmeyer GB, Roos RA, Aziz NA. Body weight is a robust predictor of clinical progression in Huntington disease. Annals of Neurology. 2017 Jan 01; 82:479-483. doi: 10.1002/ana.25007
Gardiner SL, Van Belzen MJ, Boogaard MW; Van Roon-Mom WM, Rozing MP, Van Hemert AM, Smit JH, Beekman AT, Van Grootheest G, Schoevers RA, Oude Voshaar RC, Roos RA, Comijs HC, Penninx BW, Van der Mast RC, Aziz NA. Huntingtin gene repeat size variations affect risk of lifetime depression. Translational Psychiatry. 2017 Jan 01; 7:e1143. doi: 10.1038/s41398-017-0042-1
Stuitje GA, Van Belzen MJ, Gardiner SL, Van Roon-Mom WM, Boogaard MW, REGISTRY Investigators of the European Huntington Disease Network, Tabrizi SJ, Roos RA, Aziz NA. Age of onset in Huntington disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes. Brain. 2017 Jan 01; 140:e42. doi: 10.1093/brain/awx122
Aziz NA, Tannemaat MR. A microscope for subtle movements in clinical neurology. Neurology. 2015 Jan 01; 85:920. doi: 10.1212/WNL.0000000000001914
Van der Burg JM, Pijl H, Campman YJ, Roos RA, Aziz NA. Does midlife obesity really lower dementia risk?. Lancet Diabetes & Endocrinology. 2015 Jan 01; 3:499-500. doi: 10.1016/S2213-8587(15)00217-X
Aziz NA, Pijl H, Frölich M, Snel M, Streefland T, Roelfsema F, Roos RA. Systemic energy homeostasis in Huntington’s disease patients. J Neurol Neurosurg Psychiatry. 2010 Jan 01; 81:1233-7. doi: 10.1136/jnnp.2009.191833
Aziz NA, Jurgens CK, Landwehrmeyer GB, Van Roon-Mom WM, Van Ommen GJ, Stijnen T, Roos RA. Normal and mutant HTT interact to affect clinical severity and progression in Huntington’s disease. Neurology. 2009 Jan 01; 73:1280-5. doi: 10.1212/WNL.0b013e3181bd1121
Aziz NA, Fronczek R, Maat-Schieman MA, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab DF, Roos RA. Hypocretin and Melanin-Concentrating Hormone in Patients with Huntington Disease. Brain Pathol. 2008 Jan 01; 18:474-483. doi: 10.1111/j.1750-3639.2008.00135.x
Aziz NA, Van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, EHDI Study Group; Roos RA. Weight loss in Huntington’s disease increases with higher CAG repeat number. Neurology. 2008 Jan 01; 71:1506-1513. doi: 10.1212/01.wnl.0000334276.09729.0e

Info-Hotline

Donnerstags 13.30-16.30 Uhr

Für Patienten 0800-7799001

(kostenlos)

Für Ärzte 01803-779900

(9 Cent/Min. dt. Festnetz, mobil evtl. teurer)

Willkommen auf unserer Webseite, informieren Sie sich hier grundsätzlich cookie-frei.

Wir würden uns freuen, wenn Sie für die Optimierung unseres Informationsangebots ein Cookie zu Analysezwecken zulassen. Alle Daten sind pseudonym und werden nur durch das DZNE verwendet. Wir verzichten bewusst auf Drittanbieter-Cookies. Diese Einstellung können Sie jederzeit hier ändern.

Ihr Browser erlaubt das Setzen von Cookies: